Antibody-drug conjugates for T cell cancers

Our latest publication detailing the development of antibody-drug conjugates for the treatment of T cell leukemias and lymphomas. 

​

​Nature 2024

Antibodies to treat T cell leukemias and lymphomas

Our study detailing the development of bispecific antibodies that selectively kill T cell cancers and do not harm the normal human T cells.

 

​Science Translational Medicine 2021

Antibody targeting cancers with p53 mutation

​Mutations in p53 tumor suppression gene leads to cancer. We generated an antibody that specifically kills the cancer cells carrying the mutant p53 protein.

 

​Science 2021

Antibodies targeting cancers with RAS mutations

​​Mutations in RAS oncogene lead to cancer. We generated an antibody that specifically kills the cancer cells carrying the mutant p53 protein.

​

Science Immunology 2021